Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 635-639

  Troch, Marlene ^a   Wöhrer, Stefan ^a   Raderer, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

FLIPI; IPI; MALT lymphoma; Prognostic index

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER RELAPSE; CONTROLLED STUDY; DISEASE COURSE; DISSEMINATED CANCER; FEMALE; FOLLICULAR LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERNATIONAL PROGNOSTIC INDEX; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT;

AGED; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERNATIONAL AGENCIES; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77950547953     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pileri SA, Milani M, Fraternali-Orcioni G and Sabattini E: From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? Ann Oncol 9: 607-612, 1998.
2. Zucca E, Bertoni F, Roggero E and Cavalli F: The gastric marginal zone B-cell lymphoma of MALT type. Blood 96: 410-419, 2000.
3. Raderer M, Wöhrer S, Streubel B, Troch M, Turetschek K, Jäger U, Skrabs C, Gaiger A, Drach J, Puespoek A, Formanek M, Hoffmann M, Hauff W and Chott A: Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24: 3136-3141, 2006.
4. Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, Patterson BJ, Ferreri AJ, Ponzoni M, Devizzi L, Giardini R, Pinotti G, Capella C, Zinzani PL, Pileri S, López-Guillermo A, Campo E, Ambrosetti A, Baldini L, Cavalli F; International Extranodal Lymphoma Study Group: Nongastric marginal zone B-cell lymphoma of mucosa associated lymphoid tissue. Blood 101: 2489-2495, 2003.
5. Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, Felman P and Coiffier B: Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behaviour: Analysis of 108 patients. J Clin Oncol 15: 1624-1630, 1997.
6. Raderer M, Wohrer S, Streubel B, Drach J, Jager U, Turetschek K, Troch M, Puspok A, Zielinski CC and Chott A: Activity of rituximab plus cyclophosphamid, doxoubicin/mitoxandron, vincristine and prednisone in patients with relapsed MALT lymphoma. Oncology 70: 411-417, 2006.
7. Troch M, Streubel B, Petkov V, Turetschek K, Chott A and Raderer M: Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res 27: 3633-3637, 2007.
8. Zinzani PL, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A, Marchi E, Pileri S and Baccarani M: Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 100: 2190-2194, 2004.
9. Sackmann M, Morgner A, Rudolph B, Neubauer A, Thiede C, Schulz H, Kraemer W, Boersch G, Rohde P, Seifert E, Stolte M and Bayerdoerffer E: Regression of gastric MALT-lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 113: 1087-1090, 1997.
10. Raderer M, Osterreicher C, Machold K, Formanek M, Fiebiger W, Penz M, Dragosics B and Chott A: Impaired response of gastric MALT lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol pp. 937-939, 2001.
11. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A and Isaacson PG: Du MQT(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122: 1286-1294, 2002.
12. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ and Isaacson PG: Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357: 39-40, 2001.
13. Troch M, Woehrer S, Streubel B, Weissei M, Hoffmann M, Müllauer L, Chott A and Raderer M: Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma. Ann Oncol 9(7): 1336-1339, 2008.
14. Wöhrer S, Troch M, Streubel B, Zwerina J, Skrabs C, Formanek M, Hauff W, Hoffmann M, Müllauer L, Chott A and Raderer M: MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course. Leukemia 27: 1812-1818, 2007.
15. Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M and Chott A: High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11: 3349-3352, 2005.
16. + B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 9: 105-116, 2008.
17. López-Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E and Rozman C: Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12: 1343-1348, 1994.
18. Isaacson P, Müller-Hermelink HK, Piris MA et al: Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES and Harris NL (eds.). Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, pp. 157-160, 2001.
19. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma. N Engl J Med 329: 987, 1993.
20. Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hagenbeek A, Haïoun C, LeBlanc M, Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N, Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P, Tilly H, Vitolo U, Zinzani PL, Zucca E and Montserrat E: Follicular lymphoma international prognostic index. Blood 104: 1258-1265, 2004.
21. Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Kagami Y, Maeshima A, Matsuno Y and Tobinai K: Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 17: 135-140, 2006.